Get the Daily Brief
Latest Biotech News
Novel Parkinson’s biomarkers link perivascular fluid and nerve changes
Recent studies illuminate Parkinson’s disease pathology through peripheral nervous system insights and brain fluid dynamics. One cohort study detailed structural and functional alterations in...
FDA approves pembrolizumab for head and neck cancer perioperative use
The FDA has approved pembrolizumab as a perioperative treatment for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1. The decision follows the phase...
BMS names ex-Goldman biotech analyst as chief strategy officer
Bristol Myers Squibb has appointed Dr. Chris Shibutani, a physician and former senior biotech analyst at Goldman Sachs, as EVP and chief strategy officer. Shibutani's role will encompass long-term...
Innovations in multiomics partnerships accelerate proteomics integration
Multiomics integration is advancing, particularly via strategic partnerships rather than in-house development. Ultima Genomics collaborates with Olink Proteomics to merge sequencing with...
Human Genome Project’s 25th anniversary reflections and impact
Marking 25 years since the first draft announcement, leaders including Francis Collins and J. Craig Venter reflect on the landmark Human Genome Project (HGP). Collins applauds the global...
KalVista’s FDA on-demand HAE drug decision delayed
KalVista Pharmaceuticals announced that the FDA postponed its regulatory decision on the company’s on-demand oral therapy for hereditary angioedema. The delay is attributed to the agency’s heavy...
Innovative cooling technology targets data center energy consumption
UC San Diego engineers developed a fiber membrane that removes heat via passive evaporation for cooling electronics and data centers. Published in Joule, this method offers a low-energy...
Newly developed biomaterial reveals reversible heart ageing mechanisms
Researchers at the National University of Singapore engineered DECIPHER, a hybrid biomaterial mimicking heart extracellular matrix properties to study ageing effects. Their work reveals that...
Sarepta Pauses Duchenne Gene Therapy After Second Liver Failure Death
Sarepta Therapeutics halted its Duchenne muscular dystrophy gene therapy Elevidys shipments for non-ambulatory patients after a second death from acute liver failure. Both fatalities occurred in...
Anne Wojcicki’s Nonprofit Wins 23andMe Bid at $305 Million
Anne Wojcicki, co-founder and former CEO, successfully led a nonprofit bidding team to acquire 23andMe’s assets for $305 million, outbidding Regeneron. The deal includes strong commitments to...
FDA Postpones Decision on KalVista’s Hereditary Angioedema Drug
KalVista Pharmaceuticals announced an FDA delay in its oral on-demand hereditary angioedema drug approval due to agency resource constraints. The postponement disrupts the company's development...
Sarepta Halts Duchenne Gene Therapy Amid Second Patient Death
Sarepta Therapeutics has suspended shipments of its gene therapy Elevidys for Duchenne muscular dystrophy in non-ambulatory patients following a second fatal case of acute liver failure. Both...
FDA Clears Pembrolizumab as Neoadjuvant for Head and Neck Cancer
The FDA approved pembrolizumab for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1 (CPS ≥1), based on the pivotal KEYNOTE-689 phase 3 trial....
23andMe Assets Acquired by Anne Wojcicki’s Research Nonprofit
Anne Wojcicki's TTAM Research Institute won a $305 million bidding war to acquire most assets of 23andMe, surpassing Regeneron’s $256 million offer. The agreement preserves strong consumer privacy...
Rapid Vascular Organoid Generation via Dual Transcription Factor Activation
Researchers from Boston Children’s Hospital and Harvard Medical School developed a rapid, defined method to create functional vascular organoids by simultaneously activating endothelial and mural...
Quantum Simulation Reveals Stability of Quasicrystals
University of Michigan scientists performed the first quantum-mechanical simulations to explain the fundamental stability of quasicrystals, solids exhibiting non-repeating atomic lattices and...
AI-Powered Podcasts Enhance Science Communication
A study at the University of Leuven demonstrated the effectiveness of AI-generated podcasts in summarizing scientific research, with many authors unable to distinguish them from human-hosted...
New Biomaterial Reverses Aging Effects in Heart Cells
Researchers at the National University of Singapore developed a hybrid biomaterial platform, DECIPHER, combining natural heart extracellular matrix with synthetic hydrogels to decouple and control...
Advances in Multiomics Integration via Proteomics Partnerships
Proteomics integration with sequencing technologies is advancing multiomics capabilities as firms like Ultima Genomics, Olink Proteomics, and SomaLogic collaborate to pair gene sequencing with...
KalVista Faces FDA Delay on Hereditary Angioedema Drug Approval
KalVista Pharmaceuticals announced an FDA delay in the decision on approval of its oral on-demand treatment for hereditary angioedema, attributing the postponement to agency workload and limited...